For IPO Boutique's "scale of 1 to 5" BUY rating on La Jolla Pharmaceutical Co., and our comprehensive analysis, click "Buy Market Research".
About La Jolla Pharmaceutical Co. (adapted from La Jolla Pharmaceutical Co. prospectus): They are a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.
This description is adapted from La Jolla LJPC prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as La Jolla LJPC "LJPC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?